LSTA
Lisata Therapeutics, Inc.Company with tickers: LSTA
CIK
320017
CUSIP
128058302
Shares Outstanding
9,106,391
13F Activity (30d)
31 filings
31 filers
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | $0 | USD | 2026-03-31 | 10-Q | 2026-05-11 |
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | $4,942,000 | USD | 2026-03-31 | 10-Q | 2026-05-11 |
| Research & Development | — | ||||
| Operating Income | $-4,942,000 | USD | 2026-03-31 | 10-Q | 2026-05-11 |
| Net Income | $-4,489,000 | USD | 2026-03-31 | 10-Q | 2026-05-11 |
| EPS (Basic) | $-0.50 | USD/shares | 2026-03-31 | 10-Q | 2026-05-11 |
| EPS (Diluted) | $-0.50 | USD/shares | 2026-03-31 | 10-Q | 2026-05-11 |